Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
Cet article résume les recommandations d'agences sanitaires nationales ou européennes (U.S. Food and Drug Administration, European Medicines Agency, ...) concernant les essais de cancérologie en cours durant la crise sanitaire liée au COVID-19
Clinical research has transformed cancer care and is often integrated seamlessly into routine oncology clinics, offering eligible patients additional treatment options or lines of therapy. Typically, and particularly for diseases with poor prognoses or when trials entail biomarker-directed personalised treatment, clinical trial enrolment can be preferred (by both doctors and patients) over standard care.
The Lancet Oncology , article en libre accès, 2019